News

1 to 9 of 22 results

Hospira launches first biosimilar MAb Inflectra (infliximab) in major European markets

Hospira launches first biosimilar MAb Inflectra (infliximab) in major European markets

16-02-2015

US injectable generics and biosimilars major Hospira says it has launched the first biosimilar monoclonal…

Anti-Arthritics/RheumaticsBiosimilarsCellTrionEuropeGenericsHospiraInflammatory diseasesInflectraJohnson & JohnsonMarkets & MarketingMerck & CoRemicadeRemsima

NICE now proposes to recommend Stelara for psoriatic arthritis

NICE now proposes to recommend Stelara for psoriatic arthritis

09-12-2014

UK health cost watchdog, the National Institute for Health and Care Excellence (NICE) has opened a consultation…

Anti-Arthritics/RheumaticsBiotechnologyInflammatory diseasesJanssenJohnson & JohnsonPricingRegulationStelaraUK

Positive Ph III data for AstraZeneca’s lesinurad in gout patients

17-11-2014

Anglo-Swedish pharma major AstraZeneca has presented positive top-line results of two pivotal Phase III…

allopurinolAnti-Arthritics/RheumaticsAstraZenecaInflammatory diseaseslesinuradPharmaceuticalResearch

AstraZeneca to showcase inflammation/ autoimmunity pipeline at ACR

AstraZeneca to showcase inflammation/ autoimmunity pipeline at ACR

11-11-2014

Anglo-Swedish pharma major AstraZeneca, with its global biologics R&D subsidiary MedImmune, will present…

anifrolumabAnti-Arthritics/RheumaticsAstraZenecaBiotechnologybrodalumabInflammatory diseaseslesinuradMavrilimumabMedImmuneResearchSifalimumabUSA

Bristol-Myers returns rights to clazakizumab to Alder BioPharma

Bristol-Myers returns rights to clazakizumab to Alder BioPharma

03-09-2014

USA-based drug developer Alder BioPharmaceuticals says it has regained the worldwide rights to clazakizumab,…

Alder BiopharmaceuticalsAnti-Arthritics/RheumaticsBiotechnologyBristol-Myers SquibbclazakizumabGlobalInflammatory diseasesLicensing

Novo Nordisk pulls out of inflammatory disorders research

Novo Nordisk pulls out of inflammatory disorders research

02-09-2014

Danish diabetes care giant Novo Nordisk says it has decided to discontinue all its R&D activities within…

Anti-Arthritics/RheumaticsInflammatory diseasesNovo NordiskPharmaceutical

J&J affiliate Cilag GmbH International acquires Covagen

J&J affiliate Cilag GmbH International acquires Covagen

25-08-2014

Cilag GmbH International, an affiliate of US health care giant Johnson & Johnson’s Janssen companies,…

Anti-Arthritics/RheumaticsBiotechnologyCilag GmbH InternationalCovagenFynomAbInflammatory diseasesJanssenJohnson & JohnsonMergers & Acquisitions

Positive association between adherence and anti-TNF therapy compared to conventional therapy

Positive association between adherence and anti-TNF therapy compared to conventional therapy

11-06-2014

US drugmaker AbbVie has released results from its multi-country ALIGN study, which shows that across…

AbbVieAnti-Arthritics/RheumaticsHealthcareInflammatory diseasesPharmaceutical

1 to 9 of 22 results

Back to top